| Title: |
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (Nature Cancer, (2025), 6, 3, (528-539), 10.1038/s43018-025-00921-6) |
| Authors: |
Kim, WS; Kim, TM; Cho, SG; Jarque, I; Iskierka-Jażdżewska, E; Poon, LM; Prince, HM; Zhang, H; Cao, J; Zhang, M; Tessoulin, B; Oh, SY; Lim, F; Carpio, C; Tan, TD; Ayyappan, S; Gutierrez, A; Cai, J; Ufkin, M; Shariff, S; Brouwer-Visser, J; Chaudhry, A; Mohamed, H; Ambati, S; Walewski, J; Farooq, U; Klein, A; Awan, F; Stevens, D; Vaidya, R; Villasboas, JC; Arnason, J; Venugopal, P; Leslie, L; Jagadeesh, D; Ibrahimi, S; Jandl, T; Allan, J; Elmusharaf, N; Lewis, D; Tucker, D; Kuhnl, A; Cunningham, D; Wang, MC; Wu, SJ; Yeh, SP; Chen, TY; Miqueleiz, S; Gonzalez-Barca, E; Magnano, L; Alonso, A; Cordoba, R; Coello, AP; Martin, A; Andreu, R; Jimenez-Ubieto, A; Jo, JC; Kim, BS; Kim, JS; Rok Do, Y; Mun, YC; Eom, HS; Ong, SY; Hsieh, WS; Robak, T; Wrobel, T; Knopinska-Posluszny, W; Lech-Maranda, E; Taszner, M; Yoshida, I; Nakamae, H; Jo, T; Kuroda, J; Ogawa, Y; Suehiro, Y; Nagai, H; Takeuchi, M; Yuda, J; Yamauchi, N; Minami, Y; Uchida, T; Tobai, T; Ishizawa, K; Tsukasaki, K; Yamamoto, R; Flenghi, L; Battistini, R; Tani, M; Skert, C; Brociner, M; Gaidano, G; Bagnato, L; Zinzani, PL; Luminari, S; Rossi, F; Zilioli, V; Capochiani, E; Hebart, H; La Rosee, PG; Weber, T |
| Publisher Information: |
Springer Science and Business Media LLC |
| Publication Year: |
2025 |
| Collection: |
The University of Melbourne: Digital Repository |
| Description: |
10.1038/s43018-025-00967-6 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| ISSN: |
2662-1347 |
| Relation: |
https://hdl.handle.net/11343/363360 |
| Availability: |
https://hdl.handle.net/11343/363360 |
| Rights: |
https://creativecommons.org/licenses/by/4.0 ; CC BY |
| Accession Number: |
edsbas.6CD5977D |
| Database: |
BASE |